|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 97.10 USD | -0.60% |
|
+1.26% | -1.69% |
| 14/04 | Pharma sector doubles down on AI amid hopes of slashing costs, timelines | RE |
| 08/04 | Palvella Therapeutics, Inc. Appoints Kent Taylor as Senior Vice President of Sales | CI |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 15.68x | 2.89x | -4.64x | 2.54x | 8.03x | 7.57x | -.--% | 1.93TCr | ||
| 19.2x | 2.25x | -3.59x | 4.41x | 13.12x | 13.68x | 0.52% | 7.74TCr | ||
| 29.09x | 4.09x | 2.55x | 5.8x | 16.75x | 21.06x | 0.55% | 5.97TCr | ||
| 39.01x | 7.97x | 0.72x | 13.14x | 24.06x | 28.61x | -.--% | 5.04TCr | ||
| 35.98x | 2.48x | -0.65x | 3.6x | 10.41x | 11.83x | 2.95% | 4.79TCr | ||
| 15.18x | 1.31x | 0.43x | 2.87x | 8.57x | 9.36x | -.--% | 2.65TCr | ||
| -7.51x | 3.39x | 17.92x | 8.44x | -6.46x | -6.03x | -.--% | 2.15TCr | ||
| 24.4x | 3.42x | 0.02x | 4.94x | 13.47x | 17.97x | -.--% | 1.55TCr | ||
| -39.86x | -6.4x | 0.82x | 17.96x | -50.08x | -59.08x | -.--% | 1.51TCr | ||
| 74.84x | 29.64x | 0.85x | 38.5x | 52.33x | 53.32x | 0.09% | 1.36TCr | ||
| 12.86x | - | 0.09x | 3.06x | 13.33x | 24.36x | -.--% | 1.06TCr | ||
| -210x | 59.4x | 2.76x | 9.4x | 218.15x | -216.23x | -.--% | 942.14Cr | ||
| 34.4x | - | 2.43x | - | - | - | -.--% | 790.47Cr | ||
| 85.85x | 6.07x | -1.1x | - | - | - | - | 809.35Cr | ||
| -217.92x | - | 0.67x | - | - | - | -.--% | 730.65Cr | ||
| 11.84x | 1.07x | 0.34x | 1.83x | 7.3x | 9.66x | 2.04% | 695.43Cr | ||
| 35.27x | - | 0.44x | 9.13x | 27.34x | 33.66x | 0.27% | 575.8Cr | ||
| -12.05x | 1.2x | 0.05x | 2.31x | -22.21x | -22.64x | 0.46% | 553.32Cr | ||
| 20.32x | 1.08x | 1.22x | - | - | - | 1.58% | 547.18Cr | ||
| Average | -1.76x | 7.99x | 1.12x | 8.53x | 22.27x | -4.86x | 0.47% | 2.18TCr | |
| Weighted average by Cap. | 14.76x | 5.47x | 0.64x | 7.52x | 16.66x | 7.94x | 0.6% |
- Stock Market
- Equities
- INCY Stock
- Sector Incyte Corporation
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















